CTOs on the Move

Medicine in Motion

www.medmotion.org

 
Medicine in Motion (MM) is a 501(c)(3) nonprofit organization composed of a diverse group of healthcare providers whose mission is to address medical burnout through fitness, interdisciplinary community building, and philanthropy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Angel Attic Community Inc

Angel Attic Community Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Angel Attic Community Inc is based in Middleton, WI. You can find more information on Angel Attic Community Inc at www.atticangel.org

CIMIBAS

CIMI Behavior Analytic Solutions is an ABA therapy company that serves individuals throughout Delaware. They provide evidence-based treatments for individuals with autism, with the goal of improving the quality of life for their clients and their famil...

Paradigm Medical Industries

Paradigm Medical Industries is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alignment Healthcare

Alignment Healthcare is redefining the business of health care by shifting the focus from payments to people. We`ve created a new model for health care delivery that cuts costs and improves lives by unraveling the inefficiencies of the current system to drive patients, providers and payers toward a common goal of wellness. Harnessing best practices from Medicare Advantage, our innovative data-management technology allows us to commit to caring for seniors and those who need it most: the chronically ill and frail. Alignment Healthcare provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology facilitation. Alignment Healthcare offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs.

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.